AXIL (Personal Care Products) Stock Valuation & Fair Value Mixed on our tests
AXIL (Personal Care Products) trades at a blended P/E of 13.5, about 33% below its historical normal valuation, with a forward growth estimate of 53.6% and a PEG of 0.25. Priced at its historical normal P/E of 20.3 on the same blended earnings, the 2026-10-02 close of $6.17 corresponds to about $9.26 a share. This is a valuation reference, not a price target.
No quality score is published for this company, which is normal for insurers, banks and REITs. This rating reflects valuation and forecast return, and for the top ratings, credit rating, growth and analyst accuracy.
Valuation flags
- Small company with no investment-grade credit rating
Frequently asked questions
Is AXIL overvalued?
At a blended P/E of 13.5 versus its historical normal P/E of 20.3, AXIL trades about 33% below its typical valuation, with a PEG of 0.25 on 53.6% forward growth. tickerseer currently rates it mixed on our tests.
What is AXIL's fair value and PEG?
AXIL trades at a blended P/E of 13.5 against a historical normal P/E of 20.3, a PEG of 0.25, and a forward growth estimate of 53.6%. Priced at its historical normal P/E of 20.3 on the same blended earnings, the 2026-10-02 close of $6.17 corresponds to about $9.26 a share. This is a valuation reference, not a price target.
Has tickerseer's rating of AXIL changed?
tickerseer's rating has been mixed on our tests since 2026-10-03.
Industry: Personal Care Products. Create a free account to see the full analysis: the SeerAI score, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.
Get the free weekly earnings preview
One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.
It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.